Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Molecular Imaging

Published 04 October 2011 | By CoreLab Partners

Whether your prospective compound or novel radiotracer is in the early or late stage of trial development, CoreLab Partners' Molecular Imaging services can be leveraged to successfully gather, analyze, and deliver crucial functional imaging data. For early phase trials, we work with you to provide highquality imaging efficacy data that empowers you to expedite critical go/no-go decisions. Your project team will be able to identify ineffective compounds earlier, saving valuable time and resources, while allowing only your most promising compounds to advance in your drug-development pipeline.

As a registered user of PBR you can skip the majority of this form. Registration is FREE so register now or log in if you're already a member.
Fill In Details

Help us to better improve our communications by entering all or some of the additional fields below, then click 'Download White Paper' to be taken to the next page.




Complete a quick security check and confirm terms and conditions

This step helps prevent unfair use of automated programs.
I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, or if you would prefer not to receive these, uncheck this box.
If you would prefer not to hear from carefully selected third party companies uncheck this box



By clicking the 'download white paper' button you agree to pass your details as shown to the white paper advertiser. The enquirer also permits the advertiser to follow up the enquiry by phone or email. PBR is in no way responsible for further communication between parties.
Fields marked * are compulsory